Literature DB >> 31801397

Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.

Nicholas Olson1, Rodrigo Gularte-Mérida2, Pier Selenica2,3, Arnaud Da Cruz Paula2, Barbara Alemar2, Britta Weigelt2, Joel Lefferts1, Konstantinos Linos1.   

Abstract

Aims. The aim of this study was to identify potential driver genetic alterations in a dedifferentiated liposarcoma (DDLPS) with rhabdomyosarcomatous differentiation. Methods and Results. A 24-year-old female underwent resection of an abdominal mass, which on a previous biopsy demonstrated rhabdomyosarcomatous differentiation concerning for embryonal rhabdomyosarcoma. Histologically the resected tumor displayed a high-grade sarcoma with rhabdomyosarcomatous differentiation in the background of well-differentiated liposarcoma consistent with DDLPS. Fluorescence in situ hybridization confirmed MDM2 amplification, as did array-based copy number profiling. Whole-exome sequencing revealed a somatic FGFR1 hotspot mutation and RNA sequencing an LMNB2-MAP2K6 fusion only within the dedifferentiated component. Conclusions. This study represents an in-depth examination of a rare DDLPS with rhabdomyosarcomatous differentiation in a young individual. Additionally, it is also instructive of a potential pitfall when assessing for MDM2 amplification in small biopsies. Despite exhaustive analysis, mutation and gene copy number analysis did not identify any molecular events that would underlie the rhabdomyoblastic differentiation. Our understanding of what causes some tumors to dedifferentiate as well as undergo divergent differentiation is limited, and larger studies are needed.

Entities:  

Keywords:  MDM2; amplification; dedifferentiation; liposarcoma; rhabdomyosarcoma

Mesh:

Substances:

Year:  2019        PMID: 31801397      PMCID: PMC8302235          DOI: 10.1177/1066896919890401

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  42 in total

1.  Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.

Authors:  Kunitoshi Chiba; Franziska K Lorbeer; A Hunter Shain; David T McSwiggen; Eva Schruf; Areum Oh; Jekwan Ryu; Xavier Darzacq; Boris C Bastian; Dirk Hockemeyer
Journal:  Science       Date:  2017-08-17       Impact factor: 47.728

2.  High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.

Authors:  Vera Paulson; Garvin Chandler; Dinesh Rakheja; Rene L Galindo; Kathleen Wilson; James F Amatruda; Scott Cameron
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

3.  Activating Structural Alterations in MAPK Genes Are Distinct Genetic Drivers in a Unique Subgroup Of Spitzoid Neoplasms.

Authors:  Victor L Quan; Bin Zhang; Lauren S Mohan; Katherine Shi; Maria C Isales; Elnaz Panah; Timothy J Taxter; Nike Beaubier; Kevin White; Pedram Gerami
Journal:  Am J Surg Pathol       Date:  2019-04       Impact factor: 6.394

4.  A mouse model of rhabdomyosarcoma originating from the adipocyte lineage.

Authors:  Mark E Hatley; Wei Tang; Matthew R Garcia; David Finkelstein; Douglas P Millay; Ning Liu; Jonathan Graff; Rene L Galindo; Eric N Olson
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

5.  Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.

Authors:  Matthieu Bui Nguyen Binh; Louis Guillou; Isabelle Hostein; Marie Christine Château; Francoise Collin; Alain Aurias; Bui Nguyen Binh; Eberhard Stoeckle; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

6.  MKK6 is upregulated in human esophageal, stomach, and colon cancers.

Authors:  Arif Ali Parray; Rafia Anjum Baba; Hina Fayaz Bhat; Lateef Wani; Taseem Ahmad Mokhdomi; Umar Mushtaq; Sehar Saleem Bhat; Deeba Kirmani; Sanaullah Kuchay; Mudassir Maqbool Wani; Firdous Ahmad Khanday
Journal:  Cancer Invest       Date:  2014-07-14       Impact factor: 2.176

7.  JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.

Authors:  Odette Mariani; Caroline Brennetot; Jean-Michel Coindre; Nadège Gruel; Carine Ganem; Olivier Delattre; Marc-Henri Stern; Alain Aurias
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

8.  Functional amyloid formation within mammalian tissue.

Authors:  Douglas M Fowler; Atanas V Koulov; Christelle Alory-Jost; Michael S Marks; William E Balch; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2006-01       Impact factor: 8.029

9.  Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases.

Authors:  Suvi Lokka; Andreas H Scheel; Sebastian Dango; Katja Schmitz; Rudolf Hesterberg; Josef Rüschoff; Hans-Ulrich Schildhaus
Journal:  BMC Clin Pathol       Date:  2014-07-28

10.  Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Authors:  Fresia Pareja; Alissa H Brandes; Thais Basili; Pier Selenica; Felipe C Geyer; Dan Fan; Arnaud Da Cruz Paula; Rahul Kumar; David N Brown; Rodrigo Gularte-Mérida; Barbara Alemar; Rui Bi; Raymond S Lim; Ino de Bruijn; Sho Fujisawa; Rui Gardner; Elvin Feng; Anqi Li; Edaise M da Silva; John R Lozada; Pedro Blecua; Leona Cohen-Gould; Achim A Jungbluth; Emad A Rakha; Ian O Ellis; Maria I A Edelweiss; Juan Palazzo; Larry Norton; Travis Hollmann; Marcia Edelweiss; Brian P Rubin; Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Commun       Date:  2018-08-30       Impact factor: 14.919

View more
  1 in total

Review 1.  Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers.

Authors:  Giuliana Cassinelli; Sandro Pasquali; Cinzia Lanzi
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.